Cancer Discov. 2022 Jun 2;12(6):1402-1403. doi: 10.1158/2159-8290.CD-NB2022-0031.
The NCI has launched the Molecular Characterization Initiative, which will provide tumor sequencing to children, adolescents, and young adults receiving clinical care at a Children's Oncology Group-affiliated hospital. By examining tumors at a molecular level, oncologists can make a more precise diagnosis, help determine what might be driving the cancer's growth, and assess patients' eligibility for clinical trials.
美国国家癌症研究所已经启动了分子特征分析计划，该计划将为在儿童肿瘤学组附属医院接受临床治疗的儿童、青少年和年轻人提供肿瘤测序服务。通过在分子水平上检查肿瘤，肿瘤学家可以做出更精确的诊断，帮助确定可能导致癌症生长的原因，并评估患者参加临床试验的资格。
